Norges Bank Investment Management »

Denali Therapeutics shares owned by Norges Bank Investment Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Norges Bank Investment Management from 13F filings

Historical chart of Norges Bank Investment Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Norges Bank Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 1.2M 21.46
2022-12-31 $29M 1.0M 27.81
2022-09-30 $29M 943k 30.69
2022-06-30 $25M 832k 29.43
2022-03-31 $27M 846k 32.17
2021-12-31 $38M 846k 44.60
2021-09-30 $43M 853k 50.45
2021-06-30 $58M 742k 78.44
2021-03-31 $34M 598k 57.10
2020-12-31 $72M 856k 83.76
2020-09-30 $33M 906k 35.83
2020-06-30 $23M 933k 24.18
2020-03-31 $17M 949k 17.51
2019-12-31 $11M 624k 17.42
2019-09-30 $9.6M 624k 15.32
2019-06-30 $12M 576k 20.76
2019-03-31 $13M 576k 23.22
2018-03-31 $5.2M 266k 19.69
2017-12-31 $10M 650k 15.64